Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Pathogenic Interleukin-10 Receptor Alpha Variants in Humans — Balancing Natural Selection and Clinical Implications

Aschenbrenner D. et al, (2022), Journal of Clinical Immunology

2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

KHALID S. et al, (2022), Arthritis and Rheumatology

2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

KHALID S. et al, (2022), Annals of the Rheumatic Diseases

2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis

KHALID S. et al, (2022), Annals of the Rheumatic Diseases

In vivo human keyhole limpet haemocyanin challenge in early phase drug development: A systematic review

Drennan P. et al, (2022), Clinical and Translational Science

Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis.

Ishigaki K. et al, (2022), Nat Genet

Tissue-dependent transcriptional and bacterial associations in primary sclerosing cholangitis-associated inflammatory bowel disease

Ilott NE. et al, (2022), Wellcome Open Research, 6, 199 - 199

Age-related mechanisms in the context of rheumatic disease.

Alsaleh G. et al, (2022), Nat Rev Rheumatol

Incidence, management and outcomes of very early onset inflammatory bowel diseases and infantile-onset disease: an epi-IIRN study.

Atia O. et al, (2022), Clin Gastroenterol Hepatol

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.

Grayson PC. et al, (2022), Annals of the rheumatic diseases

A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117.

Zacharopoulou P. et al, (2022), Curr Opin HIV AIDS, 17, 352 - 358

Cost-effectiveness of adalimumab for early-stage Dupuytren's disease : an economic evaluation based on a randomized controlled trial and individual-patient simulation model.

Dakin H. et al, (2022), Bone Jt Open, 3, 898 - 906

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Woelfel S. et al, (2022), Aliment Pharmacol Ther

Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.

Cavounidis A. et al, (2022), Mucosal Immunol

Macrophage Gal/GalNAc lectin 2 (MGL2)+ peritoneal antigen presenting cells during Fasciola hepatica infection are essential for regulatory T cell induction

Costa M. et al, (2022), Scientific Reports, 12

Anti-BDCA2 Antibody for Cutaneous Lupus Erythematosus.

Psarras A. and Vital EM., (2022), N Engl J Med, 387, 1528 - 1529

Degradomic identification of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP14) as an ADAMTS9 and ADAMTS20 substrate

Nandadasa S. et al, (2022)

Evaluation of the myocardial deformation in the diagnosis of rejection after heart transplantation

Costa RCPLD. et al, (2022), Frontiers in Cardiovascular Medicine, 9

It takes a village to skew a lymph node.

Thornton EE. and Arnon TI., (2022), Immunity, 55, 1751 - 1753

Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties

Costa VD. et al, (2022), International Journal of Molecular Sciences, 23, 12047 - 12047

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?